Recent Posts
- HealthInvest Returns for 2026: Meet the Companies Shaping Australian Life Sciences
- Lifesaving Capital: How impact investing is shaping the future of biotech
- Investor Relations: the quiet advantage powering ASX microcaps
- HealthInvest Sydney: Life Sciences in the Investor Spotlight
- HealthInvest September 2025
Archives
Atomo Diagnostics (ASX: AT1) presents at IRD Invest

IRD Invest is a virtual investor conference series hosted by IR Department to showcase emerging companies, and to provide an additional value-add for our investor and client networks.
We are all part of a new era. After reaching a low point in mid-2020, the investment landscape has changed dramatically. Companies, like investment markets, are adapting. We want to illustrate how our clients deal with change and provide fresh solutions to assist mitigate the effects of change.
Our third IRD Invest virtual investor conference ran over two days in late September 2021. We heard from a range of ASX listed companies that are innovating by addressing evolving consumer trends and patient needs.
- 1
